Trifluoperazine
Back to searchMolecule Structure
Scientific Name
Trifluoperazine
Description of the Drug
Trifluoperazine is a phenothiazine used to treat depression, anxiety, and agitation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00831
http://www.drugbank.ca/drugs/DB00831
Brand Name(s)
Amylozine, Stelazine, Stelazine fte
Company Owner(s)
Fosun Pharma Usa Inc, Athem Holdings Llc, Glaxosmithkline, Sandoz Inc, Watson Laboratories Inc, Ivax Pharmaceuticals Inc, Wockhardt Eu Operations (Swiss) Ag, Mylan Pharmaceuticals Inc, Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
| Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
| Atlas | trifluoperazine | ||||||
| SureChEMBL | SCHEMBL24866 | ||||||
| PharmGKB | PA451771 | ||||||
| Human Metabolome Database | HMDB0014969 | ||||||
| DrugBank | DB00831 | ||||||
| PubChem: Thomson Pharma | 14904043 | ||||||
| PubChem | 5566 | ||||||
| Mcule | MCULE-3726407978 | ||||||
| NMRShiftDB | 70021280 | ||||||
| LINCS | LSM-4010 | ||||||
| Nikkaji | J5.293K | ||||||
| PDBe | TFP | ||||||
| BindingDB | 79181 | ||||||
| EPA CompTox Dashboard | DTXSID1046928 | ||||||
| DrugCentral | 2740 | ||||||
| Brenda | 977 | 16220 | 129678 | 230160 | 6813 | 16001 | 230161 |
| ChemicalBook | CB9444115 | ||||||
| Guide to Pharmacology | 214 | ||||||
| rxnorm | TRIFLUOPERAZINE | TRIFLUOPERAZINE HYDROCHLORIDE | |||||
| KEGG Ligand | C07168 | ||||||
| ChEBI | 45951 | ||||||
| ZINC | ZINC000019418959 |
